The Saudi Arabia in-vitro diagnostics market is predicted to reach USD 932.3 Million by 2030, from USD 734.7 Million in 2024. Saudi Arabia is the largest market for in-vitro diagnostics in the GCC region. As in other countries, Saudi Arabia is facing the challenges of fighting with infectious disease including HBV, TB, HCV and HIV, as well as various chronic diseases and cancer. In-vitro diagnostics plays an important role in the detection of infectious and chronic diseases. The rising geriatric population and the high burden of chronic and infectious diseases propels the growth of Saudi Arabia in-vitro diagnostics market, as these chronic disorders can be diagnosed and monitored using in-vitro diagnostics (IVD) products. Furthermore, Saudi Arabian government is taking several initiatives to improve the healthcare sector in the country. For instance, Under Vision 2030, the Saudi Arabian Government plans to invest over USD 65 Billion to develop the country’s healthcare infrastructure. The government has set the target of privatizing 290 hospitals and 2,300 primary health centers by 2030. Also, the government seeks to improve the country’s healthcare sector by adopting digital information systems.

Recent Developments

  • In February 2025, ABL Diagnostics announced to manufacture and commercialize a full range of UltraGene PCR tests acquired from its parent company, Advanced Biological Laboratories.
  • In October 2024, Abbott Molecular was granted emergency use authorization for its Alinity m MPXV assay for diagnosis of mpox. It is a real time PCR test that will allow faster detection of the virus.
  • In January 2024, bioM?rieux announced the acquisition of LUMED, a software company that has developed a clinical decision support system to help hospitals optimize antimicrobial prescriptions and monitor healthcare-associated infections.
  • In August 2023, Sysmex Corporation announced an expansion of the Global Business Partnership Agreement (GBPA) with Roche Diagnostics International Ltd.




By Technology: Saudi Arabia IVD Market – Key Takeaways

  • On technology basis, Immunoassay and Clinical Chemistry are the dominating segment of the Saudi Arabia IVD market. Together they contributed nearly 58 percent to the total Saudi Arabia IVD market in 2024. Both these segments are likely to maintain their leading position over the forecast period.
  • Molecular Diagnostics captured over 10 percent share of the Saudi Arabia IVD market in 2024.
  • POCT and SMBG segments are competing closely to grab maximum market share of the pie. POCT is transforming diagnostic practices through its convenience and efficiency.
  • The growth of hematology market is attributed to factors such as the increasing incidences of blood disorders, growing adoption of automated hematology instruments by diagnostic laboratories, the emergence of high throughput hematology analyzers, and the introduction of technologically advanced hematology instruments.




By Application: Saudi Arabia IVD Market – Key Takeaways

  • On the basis of application, Infectious diseases and Diabetes are the leading segments of the Saudi Arabia IVD market. Together they contributed over 55 percent to the total Saudi Arabia IVD market in 2024.
  • The Saudi Government has set a goal to increase life expectancy from 75 to 80 years of age. This will be achieved primarily by addressing the disease burden of noncommunicable diseases in the country, such as cardiovascular disease (CVD).
  • Oncology application segment held 3rd highest share of the Saudi Arabia IVD market in 2023, followed by cardiovascular diseases.
  • Autoimmune Diseases was responsible for single digit share of the Saudi Arabia IVD market in 2024, while Nephrology held least share of the Saudi Arabia IVD market.




By Product: Saudi Arabia IVD Market – Key Takeaways

  • Reagents controlled highest share of the Saudi Arabia IVD market in 2024, and is expected to remain dominant over the forecast period, since reagents are a vital part of every in-vitro diagnostics test.
  • The instruments segment was responsible for over a quarter share of the Saudi Arabia IVD market in 2024. The introduction of advanced instruments offers an excellent avenue for the segment’s growth.
  • The software and services held least share of the Saudi Arabia IVD market.




By End User: Saudi Arabia IVD Market – Key Takeaways

  • Government Labs & Hospitals held largest share of the Saudi Arabia IVD market in 2024, owing to the large volume of diagnostic tests carried out in hospitals and the rising volumes of Class II and Class III in-vitro diagnostics medical devices that are being readily used for diagnostic testing.
  • Private Labs & Hospitals contributed nearly a quarter to the overall Saudi Arabia IVD market.
  • Saudi Arabian government has set the target of privatizing 290 hospitals and 2,300 primary health centers by 2030, under the Saudi Vision 2030 Plan.




iGATE RESEARCH report titled “Saudi Arabia In-Vitro Diagnostics (IVD) Market [By Segment ( Immunoassay, Clinical Chemistry, Hematology, Coagulation, Microbiology, Molecular Diagnostics, Self-Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT), Others), By Application (Infectious Diseases, Cardiovascular Diseases, Diabetes, Oncology, Nephrology, Autoimmune Diseases, Others), By Product (Reagents, Instruments, Software and Services), By End User (Government Labs & Hospitals, Private Labs & Hospitals, Others)], Share, Major Deals, Key Company Profiles, Revenue, Recent Developments - Forecast to 2030” provides a comprehensive assessment of the Saudi Arabia In-Vitro Diagnostics Market.

This 127 Pages report with 46 Figures and 8 Tables has been analyzed from 10 View Points:

1) Saudi Arabia In-Vitro Diagnostics Market and Forecast (2021 - 2030)
2) Saudi Arabia In-Vitro Diagnostics Market Share and Forecast (2021 - 2030)
3) By Segment - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2021 - 2030)
4) By Application - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2021 - 2030)
5) By Product - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2021 - 2030)
6) By End User - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2021 - 2030)
7) Saudi Arabia In-Vitro Diagnostics Market - Key Company Profiles
8) In-Vitro Diagnostics (IVD) Market – Major Deals
9) In-Vitro Diagnostics (IVD) Market - Recent Developments
10) Saudi Arabia In-Vitro Diagnostics - Market Dynamics


By Segment - Saudi Arabia IVD Market and Forecast

1. Immunoassay
2. Clinical Chemistry
3. Hematology
4. Coagulation/Hemostasis
5. Microbiology
6. Molecular Diagnostic
7. Self-Monitoring of Blood Glucose (SMBG)
8. Point of Care Testing (POCT)
9. Others


By Application - Saudi Arabia IVD Market and Forecast

1. Infectious Diseases
2. Cardiovascular Diseases
3. Diabetes
4. Oncology
5. Nephrology
6. Autoimmune Diseases
7. Others


By Product - Saudi Arabia IVD Market and Forecast

  • Reagents
  • Instruments
  • Software and Services




By End User - Saudi Arabia IVD Market and Forecast

  • Government Labs & Hospitals
  • Private Labs & Hospitals
  • Others




Saudi Arabia IVD Market - Key Company Profiles

1. Roche
2. Abbott
3. Sysmex Corporation
4. Danaher Corporation
5. Thermo Fischer Scientific Inc.
6. Siemens Healthineers
7. Biomerieux SA
8. Bio-Rad Laboratories, Inc
9. Becton Dickinson and Company
10. Nihon Kohden Corporation


Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non–printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.